PRX Related Upgrades

Jan 9, 2012 10:24 AM Buckingham Research Upgrades Par Pharmaceutical (PRX) to Buy

Mar 25, 2011 11:41 AM Par Pharma (PRX) Shares Surge Midday as BofA Merrill Upgrades to Buy

Aug 5, 2010 08:40 AM Caris & Co Upgrades Par Pharmaceutical (PRX) to Buy

Oct 15, 2009 09:19 AM Par Pharmaceuticals (PRX): Upgraded to Overweight at Barclays; target raised to $30

Oct 15, 2009 08:15 AM Barclays Upgrades Par Pharmaceutical (PRX) to Overweight

Sep 30, 2009 07:31 AM Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI

Aug 19, 2009 10:20 AM Par Pharma (PRX) Continuing Higher on Drug News, 3 Analyst Upgrades

Aug 19, 2009 07:34 AM Goldman Sachs Upgrades Par Pharmaceutical (PRX) to Neutral

Nov 14, 2008 08:50 AM Matrix Lighthouse Rating Changes 11/14

Aug 22, 2008 10:09 AM Matrix USA Rating Changes 8/22

Aug 13, 2008 10:48 AM Caris Upgrades Par Pharmaceutical (PRX) to Above Average

Jun 3, 2008 12:30 PM Matrix USA Rating Changes 6/3

May 21, 2008 10:27 AM Matrix USA Rating Changes 5/21

May 14, 2008 10:55 AM Matrix USA Rating Changes 5/14

Jan 7, 2008 11:15 AM Matrix USA Rating Changes 1/07

Dec 26, 2007 09:40 AM Matrix USA Rating Changes 12/26

Dec 3, 2007 09:13 AM Matrix USA Rating Changes 12/03

Jul 3, 2007 07:17 AM Goldman Sachs upgrades Par Pharmaceutical (PRX) to Neutral

May 21, 2007 10:24 AM Leerink Swann upgrades Par Pharmaceutical (NYSE: PRX) to Outperform

Jan 30, 2007 12:06 PM Buckingham Research Upgrades Par Pharmaceuticals (PRX) to Accumulate

Jul 7, 2006 12:10 PM Merrill Lynch upgrades Par Pharmaceutical (PRX) to Buy

Oct 28, 2005 08:40 AM Friedman Billings upgrades PRX to Outperform